Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00259662 · ClinicalTrials.gov registry record · NA
High-dose Periop Statins for Prevention of DVT
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT00259662 is a NA study that has completed, run by Yale University. The registered enrollment target is 29 participants.
The verdict
NCT00259662, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This study is designed to determine if the use of atorvastatin (Lipitor), a member of the HMG coA reductase inhibitor class of drugs referred to as statins, will reduce inflammatory responses and deep vein thrombosis formation when given in high doses in the perioperative period.
Interventions
- DRUG atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00259662
The ClinicalTrials.gov registry entry for NCT00259662 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which atorvastatin is the first listed.
NCT00259662 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00259662 about?
NCT00259662 is a clinical study titled "High-dose Periop Statins for Prevention of DVT". This study is designed to determine if the use of atorvastatin (Lipitor), a member of the HMG coA reductase inhibitor class of drugs referred to as statins, will reduce inflammatory responses and deep vein thrombosis formation when given in high doses in the perioperative period.
What is the current status of trial NCT00259662?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2005-11. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00259662?
The interventions under investigation include: atorvastatin (DRUG).
Who is sponsoring clinical trial NCT00259662?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.